liraglutide
liraglutide is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand names including Liraglutide, Victoza, liraglutide. Available dosage forms: injection, powder, injection, solution.
Drug Details
- Generic Name
- liraglutide
- Brand Names
- Liraglutide, Victoza, liraglutide, Saxenda
- Application Number
- ANDA218115
- Sponsor
- NorthStar Rx LLC
- NDC Codes
- 17
- Dosage Forms
- INJECTION, POWDER, INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- LIRAGLUTIDE
Indications and Usage
1 INDICATIONS AND USAGE Liraglutide injection is indicated: as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus Limitations of Use : Liraglutide injection contains liraglutide. Coadministration with other liraglutide-containing products is not recommended. Liraglutide injection is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated: as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus ( 1 ). Limitations of Use : Coadministration with other liraglutide-containing products is not recommended.